BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19346644)

  • 1. Current concepts in the pathology and genetics of gliomas.
    Sarkar C; Jain A; Suri V
    Indian J Cancer; 2009; 46(2):108-19. PubMed ID: 19346644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Towards a molecular classification of gliomas].
    Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
    Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and Genetics of Gliomas.
    Komori T; Muragaki Y; Chernov MF
    Prog Neurol Surg; 2018; 31():1-37. PubMed ID: 29393190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tiger behind many doors: multiple genetic pathways to malignant glioma.
    Louis DN; Gusella JF
    Trends Genet; 1995 Oct; 11(10):412-5. PubMed ID: 7482768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathologic anatomy of diffuse gliomas in the adult].
    Rousseau A
    Soins; 2009 Mar; (733):28-9. PubMed ID: 19365996
    [No Abstract]   [Full Text] [Related]  

  • 6. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
    Idbaih A; Marie Y; Lucchesi C; Pierron G; Manié E; Raynal V; Mosseri V; Hoang-Xuan K; Kujas M; Brito I; Mokhtari K; Sanson M; Barillot E; Aurias A; Delattre JY; Delattre O
    Int J Cancer; 2008 Apr; 122(8):1778-86. PubMed ID: 18076069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving toward molecular classification of diffuse gliomas in adults.
    Theeler BJ; Yung WK; Fuller GN; De Groot JF
    Neurology; 2012 Oct; 79(18):1917-26. PubMed ID: 23109653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology and molecular genetics of astrocytic gliomas.
    Reifenberger G; Collins VP
    J Mol Med (Berl); 2004 Oct; 82(10):656-70. PubMed ID: 15316624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification and grading of gliomas and meningiomas].
    Niedermayer I; Kolles H; Feiden W
    Radiologe; 1998 Nov; 38(11):888-97. PubMed ID: 9861648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways in the formation of gliomas.
    von Deimling A; Louis DN; Wiestler OD
    Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of gliomas: from morphology to molecules.
    Ferris SP; Hofmann JW; Solomon DA; Perry A
    Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].
    Lhotská H; Zemanová Z; Kramář F; Lizcová L; Svobodová K; Ransdorfová S; Bystřická D; Krejčík Z; Hrabal P; Dohnalová A; Kaiser M; Michalová K
    Klin Onkol; 2014; 27(3):183-91. PubMed ID: 24918277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and molecular genetics of oligodendroglial tumors.
    Hartmann C; Mueller W; von Deimling A
    J Mol Med (Berl); 2004 Oct; 82(10):638-55. PubMed ID: 15322700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Molecular Epidemiology.
    Bauchet L; Ostrom QT
    Neurosurg Clin N Am; 2019 Jan; 30(1):1-16. PubMed ID: 30470396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotypes in 90 human gliomas.
    Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
    Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of low- and intermediate-grade gliomas.
    Fuller CE; Perry A
    Semin Radiat Oncol; 2001 Apr; 11(2):95-102. PubMed ID: 11285547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and molecular genetic aspects of oligodendroglial neoplasms.
    Bigner SH; Rasheed BK; Wiltshire R; McLendon RE
    Neuro Oncol; 1999 Jan; 1(1):52-60. PubMed ID: 11550302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.